Study Name:

A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

         

Purpose:

 This randomized phase III trial is studying carboplatin and paclitaxel to compare how well they work with or without bevacizumab and/or cetuximab in treating patients with stage IV or recurrent non-small cell lung cancer.

Study Type: Treatment

Protocol: UIC 2010-0925 S0819

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Study Name:

Phase I Trial of Sunitinib (Sutent) Plus Topotecan in Relapsed Small Cell Lung Cancer.

         

Purpose:

 

 

Study Type:

Protocol: UIC 2008-0148 Sutent

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Study Name:

A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Completely Resected Stage IB-IIA Non-Small Cell Lung Cancer (NSCLC).

 

         

Purpose:

 This randomized phase III trial is studying chemotherapy and bevacizumab to see how well they work compared to chemotherapy alone in treating patients with stage IB, stage II, or stage IIIA non-small cell lung cancer that was removed by surgery.

Study Type: Treatment

Protocol: UIC 2007-0976 E1505

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Back to Oncology Clinical Trials Homepage